Guangdong Blue Treasure Pharmaceuticals Co., Ltd. (Blue Treasure) is a modern pharmaceutical company dedicated to manufacturing active pharmaceutical ingredients/starting materials/intermediates. Blue Treasure was founded in 1994, and is a joint venture with a total registered capital of USD 7.53 million and a total investment of USD 8.53 million. The shareholders include Livzon New North River Pharmaceutical Co., Ltd., Livzon Pharmaceutical Group Inc., China State Institute of Pharmaceutical Industry, Apotex Manitoba Inc. (Canada), and Biotecs Far East Limited (Switzerland). 

 14338125 副本.jpg

Blue Treasure is located in Qingyuan, a city near Guangzhou with sound climate in the Pearl River Delta of Guangdong province. Blue Treasure is well connecting to Guangzhou Baiyun International Airport, Beijing-Zhuhai Expressway, Guangzhou-Lechang Expressway, Guangzhou-Qingyuan Expressway, Beijing-Guangzhou Railway, and Guangzhou-Wuhan High-speed Rail. Also, the North River, a major branch of Pearl River, is well served for transportation of goods. The facilities of Blue Treasure were designed in compliance with international cGMP. Key production and testing equipment were imported form U.S.A and Switzerland.

 

FDA.jpg  TGA.jpg  COS.jpg  GMP.jpg

Blue Treasure is a typical fermentation pharmaceutical company with more than 20 years industrial experience in microbial fermentation. Blue Treasure produces the high-valued API-Pravastatin Sodium, starting material-Mevastatin/Compactin, and intermediate-Mycophenolic Acid. The products have been accredited as High-Tech products in Guangdong Province for years. The productivity has even been ranked one of the topmost in China and hits the highest level in the world.

DSC_0283-1.jpg DSC_0451.JPG DSC_0487.JPG

Blue Treasure, based on the objective of providing “High Quality Product with The Most Sincere Service”, has established a good quality management system, and operates in full compliance with internationally recognized compliance standard. For the leading product-Pravastatin Sodium, inspections respectively conducted by CFDA, U.S. FDA, TGA, and MFDS (Korea) were passed. Also, COS/CEP certificate was obtained. The products are exported worldwide. Exports also show steady increase in recent years.


版权所有©广东蓝宝制药有限公司保留一切权利。 
粤公网安备 44180202000306号  网站备案:粤ICP备16104045号 互联网药品信息服务资格证书(粤)—非经营性—2021—0443